John Noonan
InvestorManaging Partner at Lifeforce Capital
San Francisco Bay Area
Writes $500K – $5M checks · typically $25M
Find your path to John
Sign up to see every warm intro you have to John
- Paths you didn't know you had: your email and LinkedIn already hold routes to John. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
John Noonan, a former HHS senior policy official with dealmaking experience at Gerson Lehrman, is an award‑winning investor who backs drug discovery informed by hibernation biology and age‑related genetic risk.
Contact· self-published, not guessed
Invests in
AI & Machine LearningBiotechHealthtechMedical DevicesSaaS
Investments
Per curated public sources.
Colleagues at Lifeforce Capital
Frequently asked questions
- Who is John Noonan?
- John Noonan, a former HHS senior policy official with dealmaking experience at Gerson Lehrman, is an award‑winning investor who backs drug discovery informed by hibernation biology and age‑related genetic risk.
- Where does John Noonan work?
- John Noonan is Managing Partner at Lifeforce Capital.
- What does John Noonan invest in?
- John Noonan invests in AI & Machine Learning, Biotech, Healthtech, Medical Devices, SaaS.
- What check size does John Noonan write?
- John Noonan typically writes checks of $500K – $5M.
- What companies has John Noonan invested in?
- Investments tracked here include Character Bio, Fauna Bio, MindRight, Notable Labs.
About this profile. Compiled from public sources — Lifeforce Capital's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights


